A new Cannabis germplasm classification system and research strategies of non-psychoactive medicinal cannabis.
10.19540/j.cnki.cjcmm.20190916.101
- Author:
Qiu-Shi LI
1
;
Ying MENG
2
;
Shi-Lin CHEN
1
Author Information
1. Institute of Chinese Materia Medica,China Academy of Chinese Medical Sciences Beijing 100700,China.
2. College of Pharmaceutical Science,Shandong University of Traditional Chinese Medicine Ji'nan 250300,China.
- Publication Type:Journal Article
- Keywords:
CBD;
Cannabis;
germplasm;
medicinal plant breeding;
non-psychoactive medicinal cannabis;
psychoactive drug
- MeSH:
Analgesics;
Cannabis;
China;
Dronabinol;
Medical Marijuana;
Research Design
- From:
China Journal of Chinese Materia Medica
2019;44(20):4309-4316
- CountryChina
- Language:Chinese
-
Abstract:
At present,China manages cannabis into industrial and medical types. Industrial cannabis( THC<0. 3%) is grown for fiber and seed,while medical cannabis( THC>0. 3%) is prohibited from being planted and used. In recent years,breakthroughs have been made in the applications for a variety of fields of CBD,a non-psychoactive cannabinoid of Cannabis. However,China made a minimal contribution to this international research hotspot,mainly due to the outdated way of classification on cannabis. Here we reviewed the medicinal use history of cannabis,achievements in the study of Cannabis germplasm,and first proposed the three-level classification of management: psychoactive medicinal cannabis( THC>0. 3%),non-psychoactive medicinal cannabis( THC<0. 3%,high CBD)and industrial cannabis( THC<0. 3%,for fiber and seed,low CBD). Based on summarizing the research progress of the non-psychoactive medicinal cannabis,four key research strategies of breeding,sex control,plant factory,and synthetic biology are proposed.
